Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

News

      FDA Clears UZEDY Injection for Bipolar I Disorder in Adults

      Drug Development
      The U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly, extended-release injectable suspension for adults with bipolar I disorder (BD-I)....

      FDA Clears Elecsys pTau181 Alzheimer’s Test by Roche, Lilly

      Americas
      The US Food and Drug Administration (FDA) has approved a new blood test aimed at assessing Alzheimer’s disease and other cognitive impairments, potentially allowing...

      EIB, EC to Finance BioNTech’s Kigali mRNA Vaccine Facility

      Africa
      The European Investment Bank (EIB) and the European Commission (EC) are joining forces with BioNTech to push forward a mRNA vaccine facility in Kigali,...

      UK Grants Pharma Firms Early Access to Aligned Pathway

      Drug Development
      Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected. The Medicines and Healthcare products...

      US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

      Americas
      The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare and serious lung disease....

      FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

      Clinical Trials
      The FDA has granted approval to begin clinical trials of the AD-NP1 drug. It is a first-in-class drug for tissue regeneration, which targets cellular...

      US FDA Launches Fast-Track Review Scheme for Generic Drugs

      Americas
      The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within the United States, marking...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.